Subscribe to our Newsletters !!
Few developments in science and technology have be
Worldwide, millions of workers handle chemicals us
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceutica
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Mi
New Delhi, Jan 6 (PTI) Homegrown pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator to market its generic version of sulfamethoxazole and trimethoprim oral suspension used in the treatment of bacterial infections.
Sulfamethoxazole and trimethoprim oral suspension, 200 mg/40 mg per 5 mL, is indicated for the treatment and prevention of a wide variety of bacterial infections (for example, middle ear, urine, respiratory, and intestinal infections), and certain sort of pneumonia (pneumocystis-type).
Citing IQVIA MAT September 2020 data, the company said the sulfamethoxazole and trimethoprimoral suspension had estimated annual sales of about USD 19 million in the usa. PTI RKL MKJ
